A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis

Clinical trial NCT06436183 · COMPLETED

Trial details

NCT number: NCT06436183
Sponsor: Apollo Therapeutics Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis Atopic Dermatitis Dermatologic Disease Eczema Eczema Atopic Dermatitis Eczema, Atopic

Start date: 2024-05-01
Primary completion: 2025-03-26
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.